What is the typical initial treatment approach for Idiopathic Thrombocytopenic Purpura (ITP)?

What is the typical initial treatment approach for Idiopathic Thrombocytopenic Purpura (ITP)?

• A. Immediate splenectomy in all cases.
• B. Treatment may not be necessary, but exacerbations can be treated with steroids; severe cases may require immunosuppressive drugs or splenectomy.
• C. Platelet transfusion is always curative.
• D. Antibiotics are first-line therapy.

Answer: (B)

ITP is driven by autoimmune destruction of platelets, so management focuses on balancing bleeding risk with the potential benefits and risks of treatment. Many patients with mild disease can be watched without therapy because they have limited bleeding. When treatment is needed, corticosteroids are commonly started to suppress the immune attack on platelets, reduce their clearance, and typically raise the platelet count to lessen bleeding risk. If the disease is severe or does not respond to steroids or relapses, other options—such as immunosuppressive medications or splenectomy—are considered because they address the underlying immune process or remove the main site of platelet destruction, offering the possibility of longer-term remission. Platelet transfusions are not curative in ITP since the autoantibodies rapidly destroy transfused platelets, and they’re usually reserved for life-threatening bleeding as a temporary measure. Antibiotics don’t treat the condition because it’s not an infectious process.

ITP is driven by autoimmune destruction of platelets, so management focuses on balancing bleeding risk with the potential benefits and risks of treatment. Many patients with mild disease can be watched without therapy because they have limited bleeding. When treatment is needed, corticosteroids are commonly started to suppress the immune attack on platelets, reduce their clearance, and typically raise the platelet count to lessen bleeding risk. If the disease is severe or does not respond to steroids or relapses, other options—such as immunosuppressive medications or splenectomy—are considered because they address the underlying immune process or remove the main site of platelet destruction, offering the possibility of longer-term remission. Platelet transfusions are not curative in ITP since the autoantibodies rapidly destroy transfused platelets, and they’re usually reserved for life-threatening bleeding as a temporary measure. Antibiotics don’t treat the condition because it’s not an infectious process.